These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
621 related articles for article (PubMed ID: 2833686)
21. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells. Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233 [TBL] [Abstract][Full Text] [Related]
22. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate. Wong CS; Su YF; Watkins WD; Chang KJ J Pharmacol Exp Ther; 1994 Feb; 268(2):653-61. PubMed ID: 8113975 [TBL] [Abstract][Full Text] [Related]
23. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states. O'Sullivan BP; Mong S Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913 [TBL] [Abstract][Full Text] [Related]
24. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay. Clark JA; Houghten R; Pasternak GW Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663 [TBL] [Abstract][Full Text] [Related]
25. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors. Graeser D; Neubig RR Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695 [TBL] [Abstract][Full Text] [Related]
26. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Selley DE; Breivogel CS; Childers SR Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223 [TBL] [Abstract][Full Text] [Related]
27. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization. Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901 [TBL] [Abstract][Full Text] [Related]
28. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. Costa T; Klinz FJ; Vachon L; Herz A Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042 [TBL] [Abstract][Full Text] [Related]
29. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein. Ramkumar V; Stiles GL J Pharmacol Exp Ther; 1988 Sep; 246(3):1194-200. PubMed ID: 3138408 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286 [TBL] [Abstract][Full Text] [Related]
31. Regulation of guanine nucleotide turnover on Gi/Go by agonist-stimulated and spontaneously active muscarinic receptors in cardiac membranes. Quist E; Satumtira N; Vasan R Arch Biochem Biophys; 1999 Jan; 361(1):57-64. PubMed ID: 9882428 [TBL] [Abstract][Full Text] [Related]
32. [Kinetic characteristics of the effect of GTP on properties of opioid receptors]. Skliankina OA; Kurochkin IN; Varfolomeeva AD; Krekhnov BV; Zaĭtsev SV; Varfolomeev SD Biokhimiia; 1990 Jun; 55(6):1032-42. PubMed ID: 2169905 [TBL] [Abstract][Full Text] [Related]
33. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor. Bidlack JM NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974 [TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of ligand binding to opioid receptors: selective inhibition by ethanol? Rapaka RS; Bhargava HN; Renugopalakrishnan V; Collins BJ NIDA Res Monogr; 1986; 75():355-8. PubMed ID: 2828985 [TBL] [Abstract][Full Text] [Related]
35. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. Morris BJ; Millan MJ; Herz A J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828 [TBL] [Abstract][Full Text] [Related]
36. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. De Souza EB; Schmidt WK; Kuhar MJ J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773 [TBL] [Abstract][Full Text] [Related]
38. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes. Cruciani RA; Lutz RA; Munson PJ; Rodbard D J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108 [TBL] [Abstract][Full Text] [Related]
39. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions. Costa T; Lang J; Gless C; Herz A Mol Pharmacol; 1990 Mar; 37(3):383-94. PubMed ID: 2156152 [TBL] [Abstract][Full Text] [Related]
40. Binding kinetics of delta opioid receptors differ for microsomal and synaptic sites. Spain JW; Petta DE; Coscia CJ Mol Pharmacol; 1988 Jul; 34(1):23-8. PubMed ID: 2839762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]